SS-31
$47.99
SS-31 (Elamipretide) is a synthetic tetrapeptide studied for its selective interaction with mitochondrial membranes, including binding to cardiolipin in the inner mitochondrial membrane. It has been investigated in clinical and research settings for its role in mitochondrial function and cellular energy regulation pathways.
Usage Disclaimer: Research Use Only. This product is intended strictly for laboratory research and in-vitro studies. It is not for human or animal consumption, medical use, or diagnostic purposes. Any unauthorized use of this product is strictly prohibited.
FDA Compliance: FDA Notice. The statements made regarding these products have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Research Studies
Barth Syndrome Clinical Trial - FDA Approval (2025)
Human | 40mg daily | Phase 3 | FDA Approved
Led to FDA accelerated approval of FORZINITY (elamipretide) in September 2025 - the first mitochondrial-targeting therapy approved. Indicated for improving muscle strength in Barth syndrome patients ≥30kg.
Phase 2 Trial for Primary Mitochondrial Myopathy (2018)
Human | 40mg daily | 12 weeks | 36 patients
Showed significant improvements in 6-minute walk test and fatigue scores in patients with mitochondrial myopathies, with excellent safety profile and no serious adverse events.
Cardioprotection in Heart Failure Model (2019)
Human | 0.25mg/kg/hr infusion | During cardiac surgery
Reduced cardiac injury markers and improved mitochondrial function in patients undergoing cardiac surgery, suggesting powerful cardioprotective effects.
Pair your peptide order with bacteriostatic water for proper reconstitution and storage. Adding it now ensures you have everything you need when your order arrives.
Avoid delays and complete your setup in one shipment.
